Document is current
Any future updates will be listed below
-
Authors
Fukuoka, Hidenori https://orcid.org/0000-0001-9255-653X
Endo, Takaaki https://orcid.org/0009-0005-6146-6394
Tsuboi, Satoshi https://orcid.org/0000-0003-3164-0222
Fujio, Shingo https://orcid.org/0000-0001-8813-5038
-
Funding
Funding for this research was provided by:
Novo Nordisk Pharma Ltd.
- License Information
-
More Information
Article History
Accepted: 8 January 2025
First Online: 18 February 2025
Declarations
:
: The study was approved by the MINS Research Ethics Committee (MINS-REC-230201; approved on January 19, 2023).
: Not applicable.
: Not applicable.
: HF received lecture fees from Novo Nordisk Pharma Ltd. TE and ST are employees of Novo Nordisk Pharma Ltd., and report stock ownership. SF received lecture fees from Novo Nordisk Pharma Ltd.
